¿ªÔÆÌåÓý

Patient characteristics and use for bevacizumab in ophthalmology and oncology in a distributed research network 2025

Utilization and patient characteristics for the trastuzumab reference and biosimilars, and other human epidermal growth factor receptor 2 inhibitors in the United States 2024

Drug-dispensing limits within Medicaid during the COVID-19 pandemic 2021

Descriptive analysis of long- and intermediate-acting insulin and key safety outcomes in adults with type 2 diabetes mellitus 2019

Harnessing the Biologics and Biosimilars Collective Intelligence Consortium to evaluate patterns of care 2019

Development and validation of a patient satisfaction survey for comprehensive medication management 2016

Seeing the forest through the trees: improving adherence alone will not optimize medication use 2016

2376-0540

2376-1032